A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics-Reference-Cited by-同舟云学术

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics

Published:2018-04-23 Issue:14 Volume:24 Page:3292-3298
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Claret Laurent,Jin Jin Y.,Ferté Charles,Winter Helen,Girish Sandhya,Stroh Mark,He Pei,Ballinger Marcus,Sandler Alan,Joshi Amita,Rittmeyer Achim,Gandara David,Soria Jean-Charles,Bruno René

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in Melanoma;Cancers;2024-08-22

2. Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma;2024-08-06

3. Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab;Clinical Pharmacology & Therapeutics;2024-07-22

4. Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers;Clinical Pharmacology & Therapeutics;2024-07-12

5. Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with RET-altered solid tumors;Frontiers in Artificial Intelligence;2024-06-11